United Kingdom’s National Health Service Expands its Largest Public/Private Clinical Pathology Laboratory Joint Venture

GSTS Pathology Inks Pathology Testing Services Pact with KingsPath in London In the United Kingdom, clinical pathology laboratories are facing major changes in ownership, operation, and how they are funded. One very visible sign of these coming changes is the latest expansion in the nation’s largest public/private pathology testing joint venture that took effect just two weeks ago. On September 24, Serco Group, plc, announced that KingsPath, the pathology service arm of the King’s College...

UnitedHealthcare to Grade Oncologists on Compliance with Care Guidelines

Appropriate use of clinical pathology laboratory tests to detect and treat cancer will be a scorecard factor One primary goal of pay-for-performance programs is to reduce or eliminate the variability of care that physicians provide to their patients. Getting physicians to follow the recommended care protocols 100% of the time with 100% of their patients would contribute to improved outcomes, while reducing overall healthcare costs. Pathologists and clinical laboratory professionals are well...

Quintiles Expands Its China Laboratory Services to Include Anatomic Pathology Tests

CRO Company Adds Anatomic Pathology Testing Services to Serve China’s Pharma and Biotech Industries Quintiles announced that its Beijing medical laboratory will offer an enhanced menu of anatomic pathology testing services to the Chinese biopharmaceutical industry. With this action, global CRO (clinical research organization) giant Quintiles is responding to the increasing sophistication of the pharmaceutical industry in the world’s most populous country. Quintiles says the new service will...

PART ONE: More Debate in Quebec about How Pathology Labs Performed Inaccurate Breast Cancer Tests

Results of retesting 2,856 women were made public last week, putting pathology in the media spotlight In Quebec, concerns continue about the accuracy of breast cancer testing performed in the province. Last Wednesday, Quebec’s Health Minister, Yves Bolduc released the results from a project that retested breast cancer tissue from 2,856 women. This review involved cases where the original pathology analysis for estrogen receptor (ER) or HER-2 marker status by immunohistochemistry (IHC) had...

Sonic’s Diagnostic Medlab Signs New Contract with Auckland Health Boards

Dark Daily Commentary: Treat lab testing as a commodity and risk disrupting the entire healthcare system Once again, the pathology profession is seeing the consequences of the “penny wise-pound foolish” philosophy relentlessly pursued by government health bureaucrats. This time it involves the Auckland District Health Boards in New Zealand. Having signed a cut-rate, back room deal back in 2006 to save about NZ$15 million per year on lab testing (against an annual healthcare budget in the...
;